The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Falk Foundation; Incyte
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Roche
IMMUTACE: A biomarker-orientated phase II, single-arm, open-label AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate-stage hepatocellular carcinoma (HCC; AIO-HEP-0217)—Updated efficacy results.
 
Anna Saborowski
No Relationships to Disclose
 
Dirk Waldschmidt
No Relationships to Disclose
 
Jan Hinrichs
No Relationships to Disclose
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Uwe Marc Martens
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Guardant Health; MSD Oncology; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Pierre Fabre
 
Ardian Mekolli
No Relationships to Disclose
 
Enrico N De Toni
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Research Funding - AstraZeneca; Bayer; Bristol-Myer Squibb; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Celsion; Roche
 
Thomas Berg
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Roche; Sirtex Medical
Speakers' Bureau - Bayer; Eisai; Ipsen; Roche; Sirtex Medical
 
Michael Geißler
No Relationships to Disclose
 
Guido Hausner
No Relationships to Disclose
 
Martin Maenz
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Oncolytics (Inst); Roche (Inst)
 
Ursula Ehmer
Honoraria - Falk Foundation; Ipsen; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai
Research Funding - AstraZeneca (Inst); Eisai (Inst); Ipsen (Inst); Merck (Inst); Roche (Inst)
 
Marta Kirstein
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Advanced Accelerator Applications/Imaging Equipment Ltd; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daichi-Sankyo; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; Sanofi; Sirtex Medical; TERUMO; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Daichi-Sankyo; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Roche